Recombinant Ochrobactrum anthropi Thymidylate synthase (thyA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a 6-month shelf life at -20°C/-80°C, while the lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
thyA; Oant_1792; Thymidylate synthase; TS; TSase; EC 2.1.1.45
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-264
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Ochrobactrum anthropi (strain ATCC 49188 / DSM 6882 / JCM 21032 / NBRC 15819 / NCTC 12168)
Target Names
thyA
Target Protein Sequence
MRTYLDLLQH VLDNGTDRGD RTGTGTRSVF GYQMRFNLEE GFPVLTTKKL HLRSIIHELL WFLKGDTNIA YLKENGVSIW DEWADKNGDL GPVYGYQWRS WPAPDGRHID QIANLLKMLH GNPNSRRLIV SAWNPALVDE MALPPCHCLF QFYVADGKLS CQLYQRSADI FLGVPFNIAS YALLTMMIAQ VAGLKPGEFI HTLGDAHIYA NHFDQARLQL TRIPKKLPTM WINPDVKDLF AFRFEDFQLE GYEADPTIKA PIAV
Uniprot No.

Target Background

Function
Thymidylate synthase (thyA) catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP). It uses 5,10-methylenetetrahydrofolate (mTHF) as a methyl donor and reductant, producing dihydrofolate (DHF) as a byproduct. This reaction provides an intracellular de novo source of dTMP, a crucial precursor for DNA biosynthesis.
Database Links
Protein Families
Thymidylate synthase family, Bacterial-type ThyA subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Ochrobactrum anthropi and why is its thymidylate synthase significant for research?

Ochrobactrum anthropi is a gram-negative, oxidase-positive, non-fermenting bacillus belonging to the family Brucellaceae. The name "Ochrobactrum" derives from the Greek word "ochros," meaning pale yellow, which describes the characteristic colony color . Initially classified as Achromobacter, O. anthropi has gained attention as an emerging opportunistic pathogen with increasing clinical significance, particularly in immunocompromised patients .

Thymidylate synthase (thyA) from O. anthropi is of particular research interest because thyA genes function as potential alternative selectable markers to antibiotic resistance genes in genetic engineering. The thyA mutation is recessive lethal; thyA mutants cannot survive in environments with low amounts of thymidine or thymine unless complemented by a functional thyA gene . This property makes thyA an excellent candidate for selection systems that avoid antibiotic resistance markers, addressing growing concerns about antibiotic resistance spread.

What are the optimal conditions for culturing Ochrobactrum anthropi for thyA expression?

For optimal culturing of O. anthropi, researchers should consider the following evidence-based protocols:

  • Temperature: Maintain cultures at 28°C, which has been demonstrated as optimal for O. anthropi growth and enzyme production

  • Growth medium: For enzyme induction studies, use a medium containing nucleosides (3 mM), glucose (10 g), K₂HPO₄ (1 g), KH₂PO₄ (1 g), NH₄Cl (4 g), MgSO₄·7H₂O (0.3 g), and vitamins including thiamine hydrochloride, riboflavin, nicotinic acid, pantothenic acid, pyridoxine hydrochloride, and biotin

  • Cultivation time: 47-72 hours depending on the specific experimental requirements

  • Aeration: Maintain consistent shaking at 120-300 strokes/min to ensure proper oxygenation

These conditions have been shown to promote enzyme production in O. anthropi, although specific optimization for thyA expression may require further refinement based on your experimental goals.

How does recombinant O. anthropi thyA compare with thyA from other bacterial species?

The thyA gene has been well-characterized in several bacterial species, with the Lactococcus lactis thyA being particularly well-studied. Research indicates that:

  • The L. lactis thyA gene demonstrates strong expression in diverse bacterial hosts including E. coli, Rhizobium meliloti, and fluorescent Pseudomonas strains

  • When used as a selectable marker, the L. lactis thyA gene performs with efficiency comparable to ampicillin, chloramphenicol, or tetracycline resistance genes

  • The O. anthropi thyA gene likely shares functional characteristics with other bacterial thyA genes, but may possess unique properties related to its adaptation to the O. anthropi cellular environment

The specific properties of O. anthropi thyA, including substrate specificity, catalytic efficiency, and stability, would require direct experimental comparison with thyA enzymes from other sources. Such comparisons would be valuable for understanding evolutionary relationships and functional adaptations across bacterial species.

What purification strategies are most effective for recombinant O. anthropi thyA?

While specific purification protocols for O. anthropi thyA are not directly described in the literature, effective purification strategies can be developed based on protocols used for other O. anthropi enzymes. A multi-step purification process for nucleosidase from O. anthropi achieved high purity with excellent recovery:

Purification stepTotal protein (mg)Total activity (U)Specific activity (U/mg)
Cell extract1,9801980.10
Dialysis1,8705240.28
First DEAE-Sephacel chromatography9949840.99
Second DEAE-Sephacel chromatography1056756.43
Ammonium sulfate fractionation39.53017.61
Phenyl-Sepharose CL-4B chromatography20.027013.5
Sephacryl S-200 HR chromatography5.6495.917.0
MonoQ HR 5/5 chromatography0.18316.590.3

This purification protocol achieved a 903-fold purification with 8.3% recovery . For recombinant thyA, a similar strategy incorporating ion exchange chromatography (DEAE-Sephacel), hydrophobic interaction chromatography (Phenyl-Sepharose), size exclusion (Sephacryl), and high-resolution ion exchange (MonoQ) would likely be effective, with adjustments based on the specific properties of thyA.

Consider incorporating an affinity tag (His-tag or GST-tag) in your recombinant construct to facilitate initial capture and purification steps if working with a recombinant system.

How can researchers troubleshoot expression issues with recombinant O. anthropi thyA?

When encountering difficulties with recombinant thyA expression, consider these methodological approaches:

  • Codon optimization: O. anthropi has a different codon usage bias compared to common expression hosts like E. coli. Optimize the coding sequence for your expression host to improve translation efficiency.

  • Expression conditions assessment: Systematically evaluate expression parameters including:

    • Induction timing and inducer concentration

    • Post-induction temperature (lower temperatures often improve solubility)

    • Media composition, particularly for defined minimal media formulations

    • Duration of expression

  • Solubility enhancement strategies:

    • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE)

    • Use fusion partners known to enhance solubility (MBP, SUMO, Thioredoxin)

    • Add low concentrations of non-denaturing detergents during lysis

  • Expression host selection: If E. coli expression is problematic, consider alternative hosts such as:

    • Pseudomonas species, which may provide a more compatible cellular environment

    • The native O. anthropi itself, which would eliminate potential issues with codon usage and protein folding

  • Protein stability assessment: Evaluate buffer conditions (pH, ionic strength, additives) to identify formulations that maximize stability during purification and storage.

What are the structural and functional characteristics of O. anthropi thyA?

While specific structural data for O. anthropi thyA is limited in the current literature, thymidylate synthase enzymes generally share several conserved features:

  • Structural organization: Most bacterial thymidylate synthases function as homodimers, with each monomer typically consisting of approximately 30-35 kDa. By comparison, other characterized enzymes from O. anthropi, such as purine nucleosidase, have been shown to form tetrameric structures with four identical subunits and a total molecular weight of approximately 170 kDa .

  • Catalytic mechanism: Thymidylate synthase catalyzes the reductive methylation of dUMP to dTMP using 5,10-methylenetetrahydrofolate as both a methyl donor and reducing agent. This reaction is essential for DNA synthesis and cell survival.

  • Conserved domains: Key catalytic residues and binding pockets for substrate (dUMP) and cofactor (methylenetetrahydrofolate) are likely conserved in O. anthropi thyA compared to other bacterial thymidylate synthases.

  • Potential unique features: Given O. anthropi's environmental adaptability and opportunistic pathogenic nature, its thyA may possess unique adaptations that could be of interest for basic research and potential applications.

Structural determination through X-ray crystallography or cryo-electron microscopy would provide valuable insights into any unique features of O. anthropi thyA and could guide structure-based drug design efforts.

How can O. anthropi thyA be effectively used as a selectable marker in genetic engineering?

The thyA gene presents significant advantages as a selectable marker compared to traditional antibiotic resistance genes. Based on work with thyA from other bacterial species, the following methodological approach can be applied to O. anthropi thyA:

  • Generation of thyA-deficient recipient strains: Create thyA knockout strains of your target organism using CRISPR-Cas9 or traditional homologous recombination techniques. These thyA mutants will be auxotrophic for thymidine/thymine.

  • Vector construction strategy:

    • Clone the O. anthropi thyA gene into your vector of interest

    • Include appropriate promoter and terminator sequences

    • Ensure the absence of any antibiotic resistance genes in the final construct

  • Selection protocol:

    • Transform thyA-deficient recipient cells with your thyA-containing construct

    • Plate transformants on minimal media lacking thymidine/thymine

    • Only cells that have successfully acquired and express the functional thyA gene will survive

  • Verification approaches:

    • PCR confirmation of thyA integration

    • Restriction enzyme analysis

    • Sequencing of integration sites

    • Assessment of thyA expression levels

This selection system has been demonstrated to be equally efficient to antibiotic resistance selection in various bacterial hosts . A key advantage is that thyA selection can work bidirectionally—both positive selection (complementation of thyA deficiency) and negative selection (sensitivity to 5-fluorouracil in thyA+ strains) are possible.

What kinetic parameters characterize O. anthropi thyA activity, and how can researchers accurately measure them?

While specific kinetic data for O. anthropi thyA are not directly available in the provided literature, researchers can employ the following methodological approaches to determine these important parameters:

  • Spectrophotometric assays: The standard assay monitors the increase in absorbance at 340 nm due to the conversion of 5,10-methylenetetrahydrofolate to dihydrofolate during the reaction. This approach allows for:

    • Determination of Km values for both dUMP and 5,10-methylenetetrahydrofolate

    • Calculation of kcat and catalytic efficiency (kcat/Km)

    • Evaluation of potential inhibitors

  • Tritium release assay: Using [5-³H]dUMP as substrate, measure the release of tritium into water during the reaction. This highly sensitive method is particularly useful for:

    • Detecting low enzyme activities

    • Studying enzyme variants with reduced catalytic efficiency

    • Measuring activity in complex biological samples

  • Experimental considerations:

    • Temperature and pH optimization: Based on other O. anthropi enzymes, initial activity assessments should evaluate a pH range of 4.5-6.5 and temperatures around 50°C, which have been identified as optimal for nucleosidase activity

    • Buffer composition: Test various buffer systems and ionic strengths to identify optimal assay conditions

    • Divalent cation requirements: Evaluate the effect of Mg²⁺, Mn²⁺, and other divalent cations on enzyme activity

  • Data analysis approaches:

    • Use non-linear regression for accurate determination of kinetic parameters

    • Apply appropriate models for inhibition studies (competitive, non-competitive, uncompetitive)

    • Consider cooperative binding effects if apparent from initial velocity studies

By systematically characterizing these kinetic parameters, researchers can gain insights into the catalytic mechanism and potential applications of O. anthropi thyA.

What are the best heterologous expression systems for producing recombinant O. anthropi thyA?

When selecting an expression system for recombinant O. anthropi thyA, researchers should consider these evidence-based approaches:

  • E. coli expression systems:

    • BL21(DE3) and its derivatives offer high-level expression for many bacterial proteins

    • Consider specialized strains like Rosetta (addressing rare codon usage) or SHuffle (enhancing disulfide bond formation)

    • Evaluation of different promoter systems (T7, tac, araBAD) is recommended to optimize expression levels

  • Alternative bacterial hosts:

    • Pseudomonas species may provide a more compatible cellular environment for O. anthropi proteins

    • Research on the L. lactis thyA gene demonstrated strong expression across diverse bacterial hosts including E. coli, Rhizobium meliloti, and fluorescent Pseudomonas strains

  • Expression vector design considerations:

    • Include affinity tags (His6, GST, MBP) for simplified purification

    • Consider fusion partners that enhance solubility

    • Include precision protease cleavage sites for tag removal

    • Optimize ribosome binding site strength and spacing

  • Induction strategies:

    • IPTG concentration titration (typically 0.1-1.0 mM for T7-based systems)

    • Auto-induction media for T7-based systems

    • Temperature modulation during induction phase (typically 16-30°C)

The optimal expression system should be determined empirically through small-scale expression trials, analyzing both expression level and solubility of the recombinant protein.

How can researchers investigate potential interactions between O. anthropi thyA and other metabolic enzymes?

Understanding the protein-protein interactions and metabolic context of O. anthropi thyA requires systematic experimental approaches:

  • Affinity purification coupled with mass spectrometry (AP-MS):

    • Express tagged thyA in O. anthropi or heterologous hosts

    • Perform pull-down experiments under physiological conditions

    • Identify co-purifying proteins by mass spectrometry

    • Confirm direct interactions with orthogonal methods

  • Bacterial two-hybrid system:

    • Screen for potential binding partners using a thyA bait construct

    • Validate interactions using complementary approaches

    • Map interaction domains through truncation analysis

  • Metabolic profiling:

    • Compare metabolite profiles between wild-type and thyA mutant strains

    • Use stable isotope labeling to track metabolic fluxes

    • Correlate metabolic changes with enzyme expression levels

  • Co-immunoprecipitation studies:

    • Generate specific antibodies against O. anthropi thyA or use epitope tags

    • Isolate native protein complexes under varying physiological conditions

    • Identify interaction partners by western blotting or mass spectrometry

  • Proximity labeling approaches:

    • Fuse thyA to biotin ligase variants (BioID, TurboID)

    • Identify proteins in close proximity through biotinylation and streptavidin capture

    • This approach is particularly valuable for detecting transient interactions

These methodological approaches will provide insights into the functional integration of thyA within the broader metabolic network of O. anthropi.

How can O. anthropi thyA be utilized in synthetic biology applications?

The thyA gene from O. anthropi presents several promising applications in synthetic biology:

  • Antibiotic-free selection systems:

    • Construction of plasmids completely free of antibiotic resistance genes, such as pPR602 which was developed using thyA from L. lactis

    • Development of thyA-based CRISPR-Cas delivery systems without antibiotic selection

    • Creation of environmentally safer biocontainment strategies

  • Metabolic engineering applications:

    • Integration into synthetic pathways requiring thymidylate synthesis

    • Development of conditional growth control systems

    • Creation of auxotrophic strains for biocontainment

  • Biosensor development:

    • Engineering thyA-based reporter systems to monitor metabolic states

    • Creating biosensors for thymidylate synthesis pathway intermediates

    • Developing high-throughput screening systems based on thyA complementation

  • Orthogonal replication systems:

    • Development of specialized genetic circuits using thyA-dependent DNA synthesis

    • Creation of genetic isolations between different cellular processes

These applications leverage the essential nature of thyA in cellular metabolism and its potential as a non-antibiotic selectable marker.

What are the most promising research directions for understanding O. anthropi thyA structure-function relationships?

Future research on O. anthropi thyA should focus on these high-impact areas:

  • Structural biology approaches:

    • X-ray crystallography or cryo-EM studies to determine high-resolution structures

    • Comparison with thymidylate synthases from other bacterial species

    • Structure-guided design of selective inhibitors

  • Directed evolution strategies:

    • Development of thyA variants with enhanced catalytic efficiency

    • Engineering variants with altered substrate specificity

    • Creation of thermostable variants for biotechnological applications

  • Comparative genomics:

    • Analysis of thyA sequence conservation across Ochrobactrum species

    • Identification of unique features compared to thymidylate synthases from other bacteria

    • Investigation of horizontal gene transfer events involving thyA genes

  • Regulatory network analysis:

    • Characterization of transcriptional and post-transcriptional regulation

    • Investigation of allosteric regulation mechanisms

    • Analysis of thyA expression under different growth conditions and stresses

  • Enzyme mechanism investigations:

    • Detailed kinetic analysis of the catalytic mechanism

    • Identification of rate-limiting steps

    • Characterization of transition state structures

These research directions would significantly advance our understanding of O. anthropi thyA and potentially lead to novel applications in biotechnology and medicine.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.